Skip to main content

Advertisement

Table 3 Clinical outcome and task performance

From: Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy

  MPH (n = 16) ATX (n = 14) p value
Pre- Post- Pre- Post- MPH ATX  
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Pre vs posta Pre vs posta Time × Drug Interactionb 
ARF 30.63 (10.65) 17.06 (10.51) 32.29 (13.46) 22.71 (10.54) 0.000 0.001 0.208
ARI 16.75 (5.52) 10.13 (6.01) 18.29 (6.84) 13.71 (6.27) 0.000 0.010 0.272
ARH 13.88 (6.72) 6.94 (5.47) 14.00 (7.99) 9.00 (4.84) 0.000 0.002 0.295
SCWC-1 18.31 (7.66) 27.75 (11.70) 25.86 (8.76) 33.79 (13.57) 0.000 0.000 0.520
SCWC-2 19.81 (9.56) 28.13 (10.54) 29.36 (11.11) 33.50 (12.82) 0.000 0.033 0.098
SCWC-3 21.19 (9.17) 26.44 (10.91) 25.36 (10.35) 34.07 (12.16) 0.006 0.002 0.210
  1. MPH methylphenidate, ATX atomoxetine, ARF ADHD RS IV-J full scores, ARI ADHD RS IV-J inattention subscale scores, ARH ADHD RS IV-J hyperactivity subscale scores, SCWC-1 Stroop color-word task number of correct answers first time, SCWC-2 Stroop color-word task number of correct answers second time, SCWC-3 Stroop color-word task number of correct answers third time
  2. aTwo-tailed paired t test
  3. bTwo-way factorial ANOVA